I graduated summa cum laude from Bogazici University and went on to complete my Ph.D. at the University of Miami, where I focused on the nanoarchitectonics of carbon-based nanomaterials for cancer nanomedicine. My doctoral research involved developing targeted drug delivery systems, resulting in five first-author publications and a total of 15 papers with over 330 citations. Currently, as a postdoctoral researcher in Dr. Nimer’s lab, I am investigating transcriptional regulation in normal and malignant hematopoiesis, with a focus on identifying and targeting epigenetic regulators like PRMTs and lysine acetyltransferases in AML and MDS.
My extensive background in cancer nanomedicine, molecular biology, and medicinal chemistry has equipped me with a strong foundation to dissect the underlying biochemical mechanisms of AML. This work aligns with my long-term goal of translating epigenetic insights into therapeutic interventions for hematologic cancers.